Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More
Xconomy
JUNE 10, 2016
The results give the company confidence it can expand its tests to screen for early cancer in high-risk people who are otherwise healthy. —At the annual BIO conference, which gathered in San Francisco for the first time since cops battled street protesters in 2004, industry bigwigs took to the stage to defend themselves. .
67 
Let's personalize your content